Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps. The change, announced Monday by U.S. Agriculture Secretary Brooke Rollins, will affect about 152,000 low-income residents in Nebraska. It will take effect on Jan. 1,… read on > read on >
Nearly 18,000 tubs of ice cream and frozen yogurt have been recalled because they may contain plastic pieces. Wells Enterprises, an Iowa-based ice cream manufacturer, voluntarily recalled the products last month. Its brands include Blue Bunny and Halo Top ice cream products, according to the Associated Press. The nationwide recall affects 22 flavors of frozen… read on > read on >
Publix is recalling one of its popular GreenWise baby food pouches because it may contain lead, the company said this week. The recalled product is the Pear, Kiwi, Spinach & Pea Baby Food pouch. The supermarket chain said it found the issue through routine testing and pulled the pouches off store shelves, NBC News reported.… read on > read on >
Women who don’t brush and floss frequently are more likely to suffer from migraines and fibromyalgia, a new study says. Women with the worst oral health have a 60% higher risk of moderate to severe body pain, and a 49% greater risk of migraine headaches, researchers reported in the journal Frontiers in Pain Research. Mouth… read on > read on >
Program includes review of existing chemicals, developing final, systematic process for postmarket review read on >
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people. The vaccine is now approved for adults ages 65 and older, or for people ages 12 to 64 who have at least one health condition that puts them at higher risk of serious illness from… read on > read on >
Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared with weight-loss surgery, researchers report in the journal eClinicalMedicine. “We do not yet… read on > read on >
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million in upfront and short-term milestone payments, plus future rewards tied to research, development… read on > read on >
A new report says rice sold in U.S. stores contains toxic heavy metals, including arsenic, cadmium, lead and mercury. The report — released by Healthy Babies, Bright Futures — found arsenic in 100% of rice samples tested from stores in 20 metro areas, including New York City, Los Angeles and Miami, CBS News reported. What’s… read on > read on >
Low-income Medicare beneficiaries are more likely to die if they lose access to crucial medication coverage, a new study says. More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces their drug costs, researchers said in background notes. People who lose LIS eligibility are 4% more likely… read on > read on >
